Hangming Dong
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Ferroptosis and cancer prognosis
Papers in
-
- Heat shock proteins research 10
- Gut microbiota and health 4
- Wnt/β-catenin signaling in development and cancer 4
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Inhalation and Respiratory Drug Delivery 3
- Co-authors
- Shaoxi Cai (33 shared papers)Haijin Zhao (24 shared papers)Fei Zou (15 shared papers)Mengchen Zou (14 shared papers)Wei Li (5 shared papers)Lihong Yao (6 shared papers)Priyamvada Jayaprakash (3 shared papers)David T. Woodley (3 shared papers)
- Journals
- Toxicology Letters (4 papers)Cellular Immunology (3 papers)International Journal of Molecular Medicine (3 papers)The FASEB Journal (2 papers)Respiratory Research (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hangming Dong
50 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 96
- Clinical Biochemistry 70
- Pulmonary and Respiratory Medicine 205
- Molecular Biology 460
- Immunology and Allergy 36
- Cancer Research 83
Countries citing papers authored by Hangming Dong
This map shows the geographic impact of Hangming Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangming Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangming Dong more than expected).
Fields of papers citing papers by Hangming Dong
This network shows the impact of papers produced by Hangming Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangming Dong. The network helps show where Hangming Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Hangming Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The characterization of lung microbiome in lung cancer patients with different clinicopathology. | 2019 | 97 |
| 2 | 2022 | 64 | |
| 3 | 2016 | 60 | |
| 4 | 2024 | 56 | |
| 5 | 2015 | 55 | |
| 6 | 2016 | 54 | |
| 7 | 2014 | 51 | |
| 8 | 2016 | 45 | |
| 9 | 2016 | 42 | |
| 10 | 2017 | 33 | |
| 11 | 2023 | 32 | |
| 12 | 2015 | 31 | |
| 13 | 2021 | 30 | |
| 14 | 2013 | 30 | |
| 15 | 2017 | 28 | |
| 16 | 2017 | 24 | |
| 17 | 2022 | 20 | |
| 18 | 2015 | 20 | |
| 19 | 2015 | 19 | |
| 20 | 2017 | 19 |
About Hangming Dong
Hangming Dong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Physiology, Clinical Biochemistry and Immunology, having authored 53 papers that have together received 1.1k indexed citations. Recurring topics across this work include Heat shock proteins research (10 papers), Asthma and respiratory diseases (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Advanced Glycation End Products research (6 papers), Gut microbiota and health (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Dermatology and Skin Diseases (4 papers) and Inhalation and Respiratory Drug Delivery (3 papers). The work is most often cited by research in Clinical Biochemistry (70 citations), Pulmonary and Respiratory Medicine (205 citations), Molecular Biology (460 citations), Immunology and Allergy (36 citations) and Cancer Research (83 citations). Hangming Dong has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shaoxi Cai, Haijin Zhao, Fei Zou, Mengchen Zou, Wei Li, Lihong Yao, Priyamvada Jayaprakash, David T. Woodley, Mei Chen and Xiaojing Meng. Their work appears in journals such as Toxicology Letters, Cellular Immunology, International Journal of Molecular Medicine, The FASEB Journal and Respiratory Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.